Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Hyperglycaemia is a frequent finding in acute ischemic stroke and associated with poor
outcome. But the modalities of glucose lowering are still debated. This study will test the
efficacy and safety of continuous intravenous insulin protocol versus usual subcutaneous
insulin in acute ischemic stroke.